Azilsartan medoxomil

Active ingredient description

Azilsartan medoxomil is an orally active prodrug that is rapidly converted to the active moiety, azilsartan, which selectively antagonises the effects of angiotensin II by blocking its binding to the AT1 receptor in multiple tissues. Angiotensin II is the principal pressor agent of the RAAS, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
C09CA09
Azilsartan medoxomil
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA09

Medicines

Azilsartan medoxomil is the active ingredient of these drugs:

Drug
Countries
EDARBI

Austria Brazil Canada Germany Hong Kong

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
EDARBI Tablet
Summary of product characteristics (SPC)

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

LL0G25K7I2 - AZILSARTAN MEDOXOMIL

CAS registry number

863031-21-4 - azilsartan medoxomil

SNOMED-CT

449561004 - Azilsartan medoxomil (substance)

Next: Usage